Status:
COMPLETED
Study of Safety and Efficacy of an Oral Contraceptive
Lead Sponsor:
Warner Chilcott
Conditions:
Prevention of Pregnancy
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
This is a comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the in...
Eligibility Criteria
Inclusion
- Healthy Women
- Age 18-45
- At risk for pregnancy
- History of regular cycles
Exclusion
- Contraindications for use of hormonal contraception
- Conditions which affect the absorption or metabolism of steroid hormones
- BMI \> 35
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2004
Estimated Enrollment :
938 Patients enrolled
Trial Details
Trial ID
NCT00932321
Start Date
January 1 2004
End Date
November 1 2004
Last Update
April 22 2013
Active Locations (34)
Enter a location and click search to find clinical trials sorted by distance.
1
Warner Chilcott Investigational Site
Birmingham, Alabama, United States, 35233
2
Warner Chilcott Investigational Site
Phoenix, Arizona, United States, 85014
3
Warner Chilcott Investigational Site
Phoenix, Arizona, United States, 85031
4
Warner Chilcott Investigational Site
Chico, California, United States, 95929